ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1535

Epidemiology and Treatment Outcome of ANCA-associated Vasculitis in South Korea: A Nationwide, Population-based Cohort Study

Ji In Jung1, Jun Won Park2, Song Jihun3, Seulggie Choi2, Sun Jae Park3, Sang Min Park2 and Eun Young Lee4, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Seoul National University Hospital, Seoul, South Korea, 3Seoul National University Graduate School, Seoul, South Korea, 4Seoul National University College of Medicine, Seoul, South Korea

Meeting: ACR Convergence 2023

Keywords: ANCA associated vasculitis, Epidemiology, Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Previous studies on AAV have shown that the epidemiology and clinical features of GPA and MPA differ among countries. Considering their high mortality and morbidity, establishing a national epidemiology for GPA and MPA is necessary for physicians and healthcare systems to estimate the impact and burden of AAV. In this study, we investigated the epidemiological features of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in South Korea.

Methods: We identified index cases of GPA and MPA using the 2010-2018 Korean National Health Insurance Service database and Rare Intractable Disease registry for the entire Korean population. Each disease’s incidence and prevalence rates and trends over time were analysed. To assess the impact of disease on morbidity and mortality, a comparator group indicating the general population was established using nearest neighbourhood matching by age, sex, income, and comorbidity index, at a 5:1 ratio. Morbidity outcomes included the initiation of renal replacement therapy and admission to the intensive care unit (ICU).

Results: A total of 546 and 795 patients with GPA and MPA, respectively, were identified. The incidence rates of both diseases increased with age, and the peak incidence rate was observed in patients aged > 70 years. GPA and MPA showed different trends in incidence rates over time. In 2010, the annual incidence rates (per million) of GPA and MPA were 1.03 and 0.83, respectively. The incidence of MPA has continuously increased over time and increased to 3.26 in 2018. In contrast, the annual incidence of GPA did not significantly change during the observation period and was 1.33 in 2018 (Figure 1).

During the observation period, 90 (28.3%) and 187 (38.6%) patients in the GPA and MPA groups, respectively, died. Although all-cause mortality rates in the GPA and MPA group were significantly higher compared to that in each comparator group (adjusted HR 5.15 [3.21 to 8.38] and 8.62 [6.52 to 11.4], respectively), it was even higher in patients with MPA (adjusted HR 1.69 [1.31 to 2.18]). Patients in the GPA and MPA groups also showed a significantly higher risk of renal replacement therapy and ICU admission than those in the comparator population. In both groups, mortality and morbidity outcomes occurred mainly within the first year from the diagnosis of underlying vasculitis (Figure 2).

Conclusion: In South Korea, the incidence of MPA has increased over time. Although both GPA and MPA had high rates of mortality and morbidity, MPA has a poorer prognosis than GPA.

Supporting image 1

Annual incidence (A) and prevalence (B) rates (per million) of GPA and MPA over time.

Supporting image 2

Kaplan-Meier curves indicating cumulative incidence of all-cause mortality, renal replacement therapy (RRT), and admission to intensive care unit (ICU) compared to the comparator group in patients with GPA (A) and MPA (B). Direct comparison of the incidence of these outcomes showed that all-cause mortality, RRT, and ICU care were more common in patients with MPA (C).


Disclosures: J. Jung: None; J. Park: None; S. Jihun: None; S. Choi: None; S. Park: None; S. Park: None; E. Lee: None.

To cite this abstract in AMA style:

Jung J, Park J, Jihun S, Choi S, Park S, Park S, Lee E. Epidemiology and Treatment Outcome of ANCA-associated Vasculitis in South Korea: A Nationwide, Population-based Cohort Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/epidemiology-and-treatment-outcome-of-anca-associated-vasculitis-in-south-korea-a-nationwide-population-based-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-and-treatment-outcome-of-anca-associated-vasculitis-in-south-korea-a-nationwide-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology